Advanced search

Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial.

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
FOCAN, C, M BEAUDUIN, E SALAMON, J DE GREVE, G DE WASCH, JP LOBELLE, F MAJOIS, et al. 2001. “Adjuvant High-dose Medroxyprogesterone Acetate for Early Breast Cancer: 13 Years Update in a Multicentre Randomized Trial.” British Journal of Cancer 85 (1): 1–8.
APA
FOCAN, C., BEAUDUIN, M., SALAMON, E., DE GREVE, J., DE WASCH, G., LOBELLE, J., MAJOIS, F., et al. (2001). Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial. BRITISH JOURNAL OF CANCER, 85(1), 1–8.
Vancouver
1.
FOCAN C, BEAUDUIN M, SALAMON E, DE GREVE J, DE WASCH G, LOBELLE J, et al. Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial. BRITISH JOURNAL OF CANCER. 2001;85(1):1–8.
MLA
FOCAN, C, M BEAUDUIN, E SALAMON, et al. “Adjuvant High-dose Medroxyprogesterone Acetate for Early Breast Cancer: 13 Years Update in a Multicentre Randomized Trial.” BRITISH JOURNAL OF CANCER 85.1 (2001): 1–8. Print.
@article{140443,
  author       = {FOCAN, C and BEAUDUIN, M and SALAMON, E and DE GREVE, J and DE WASCH, G and LOBELLE, JP and MAJOIS, F and TAGNON, A and TYTGAT, J and Van Belle, Simon and VANDERVELLEN, R and VINDEVOGHEL, A},
  issn         = {0007-0920},
  journal      = {BRITISH JOURNAL OF CANCER},
  language     = {eng},
  number       = {1},
  pages        = {1--8},
  title        = {Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial.},
  volume       = {85},
  year         = {2001},
}

Web of Science
Times cited: